Japanese drug maker Astellas Pharma offered approximately $1 billion to acquire CV Therapeutics Inc. (Nasdaq: CVTX). The stock price leaped $4.62 to $15.97.
Astellas Offers $1 Billion For CV Therapeutics
January 27, 2009 at 13:40 PM EST
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.